Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
Almost half of patients with coronavirus disease 2019 (COVID-19) do not achieve clear clinical and radiological remission within 10 days after hospitalization, reveals a recent study. Factors associated with poor prognosis include male sex, anorexia and no fever upon admission.
Increased levels of serum high-mobility group box 1 (HMGB1) is associated with earlier onset of acute exacerbation (AE) in stable idiopathic pulmonary fibrosis (IPF) patients and shorter survival in those with AE-IPF, a recent study has shown. This signifies that HMGB1 predicts the acute deterioration of IPF.
Neurodevelopmental impairment (NDI) appears to be relatively rare among children with moderate-to-severe bronchopulmonary dysplasia (BPD), but the risk is higher for those with low birth weight and with longer hospital stays, a recent study has found.
Use of antibiotics and systemic corticosteroids can help decrease treatment failure in adults with mild-to-severe exacerbation of chronic obstructive pulmonary disease (COPD), results of a systematic review and meta-analysis have shown.
A blood eosinophil value of <0.144 × 109/L on admission or <2 percent is predictive of a longer hospital length of stay (LOS) among patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), suggests a study.
Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.
Adult inpatients with the 2019 coronavirus disease (COVID-19) are at an increased risk of mortality if they are older, have high Sequential Organ Failure Assessment (SOFA) score and d-dimer >1 μg/mL, according to a China study. Viral shedding can last for up to 37 days among survivors, while the virus appears to be detectable until death among nonsurvivors.
Lack of resources, competing national priorities and a high turnover of healthcare workers hamper many countries in their efforts to combat the 2019 coronavirus disease (COVID-19) pandemic, reveals a study.